Suchergebnisse - "Sarilumab"

PubPharm (319)

101

Anti-Interleukin-6 Antibodies for Autoimmune Retinopathy with Macular Edema

enthalten in: Ophthalmology. Retina | 2022

von Deaner, J. | Jaffe, G. | Keenan, R. | +2

102

Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19 : A network meta-analysis

enthalten in: PloS one | 2022

von Godolphin, P. | Fisher, D. | Berry, L. | +10

103

Efficacy and Safety of Sarilumab in patients with COVID19 Pneumonia : A Randomized, Phase III Clinical Trial (SARTRE Study)

enthalten in: Infectious diseases and therapy | 2021

von Sancho-López, A. | Caballero-Bermejo, A. | Ruiz-Antorán, B. | +120

104

Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data

enthalten in: Rheumatology and therapy | 2021

von Rehberg, M. | Giegerich, C. | Praestgaard, A. | +9

ErratumIn: Rheumatol Ther. 2021 Oct 29;:. - PMID 34714512

105

SARS-CoV-2 Spike Protein-Induced Interleukin 6 Signaling Is Blocked by a Plant-Produced Anti-Interleukin 6 Receptor Monoclonal Antibody

enthalten in: Vaccines | 2021

von Jugler, C. | Sun, H. | Chen, Q.

106

Efficacy of IL-6 antagonists in the treatment of COVID-19 patients : further randomized controlled trials are warranted

enthalten in: Human cell | 2021

von Panda, A. | Padhi, S. | Pati, A. | +1

107

Drugs for rheumatoid arthritis

enthalten in: The Medical letter on drugs and therapeutics | 2021

108

Expanded Table : Some biologic drugs and JAK inhibitors for rheumatoid arthritis

enthalten in: The Medical letter on drugs and therapeutics | 2021

109

Criteria for the optimal use of interleukin-6 receptor blockers in patients with COVID-19

enthalten in: Terapevticheskii arkhiv | 2021

von Kruglova, T. | Fomina, D. | Poteshkina, N. | +9

110

Long-term safety and efficacy of sarilumab over 5 years in patients with rheumatoid arthritis refractory to TNF inhibitors

enthalten in: Rheumatology (Oxford, England) | 2021

von Fleischmann, R. | Genovese, M. | Maslova, K. | +3

CommentIn: Rheumatology (Oxford). 2021 Nov 3;60(11):4953-4955. - PMID 33974043